Pharmacist Moms Group^™

Pharmacists play a vital role in managing multiple sclerosis treatments, enhancing patient care through clinical trials and personalized therapy options.

Discover the significance of PIRA in multiple sclerosis and how pharmacists enhance early detection and patient care in MS management.

Explore innovative strategies for identifying and managing multiple sclerosis through expert insights on biomarker-driven care and clinical practices.

Multidisciplinary coordination and streamlined workflows enabled rapid patient access to plozasiran after FDA approval at Stony Brook University Hospital.

Explore the latest FDA-approved treatments for hemophilia, including fitusiran and new anti-tissue factor inhibitors, enhancing patient care.

In this episode, the panel discusses key considerations for selecting and dosing VMAT2 inhibitors in tardive dyskinesia.

In this episode, the panel reviews the efficacy and safety data supporting deutetrabenazine and valbenazine for tardive dyskinesia.